Villagrán-García M, Velasco R.
Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors – a growing issue in neuro-oncology practice.
Neurol Sci 2022, 43 (4): 2339-2361. IF: 3.300.
doi: 10.1007/s10072-022-05920-4.
Nieto-Nicolau N, López-Chicón P, Torrico C, Bolívar S, Contreras-Carreton E, Udina E, Navarro X, Casaroli-Marano RP, Fariñas O, Vilarrodona A.
“Off-the-Shelf” nerve matrix preservation.
Biopreserv Biobank 2022, 20 (1): 48-58. IF: 1,600.
doi: 10.1089/bio.2020.0158.
Rubio MA, Herrando-Grabulosa M, Velasco R, Blasco I, Povedano M, Navarro X.
TDP-43 cytoplasmic translocation in the skin fibroblasts of ALS patients.
Cells 2022, 11 (2): 209. IF: 6,000.
doi: 10.3390/cells11020209.
Leal-Julià M, Vilches JJ, Onieva A, Verdés S, Sánchez Á, Chillón M, Navarro X, Bosch A.
Proteomic quantitative study of dorsal root ganglia and sciatic nerve in type 2 diabetic mice.
Mol Metab 2022, 55: 101408. IF: 8,100.
doi: 10.1016/j.molmet.2021.101408
Sanchez-Fernandez A, Zandee S, Mastrogiovann M, Charabati M, Rubbo H, Prat A, Lopez-Vales R.
Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis.
J Neuroinflammation 2022, 19 (1): 27. IF: 9.300.
doi: 10.1186/s12974-022-02386-1.
Amo-Aparicio J, Garcia-Garcia J, Puigdomenech M, Francos-Quijorna I, Skouras DB, Dinarello CA, López-Vales R.
Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury.
Exp Neurol 2022, 347: 113889. IF: 5.300.
doi: 10.1016/j.expneurol.2021.113889.
Mastrogiovanni M, Trostchansky A, Naya H, Dominguez R, Marco C, Povedano M, López-Vales R, Rubbo H.
HPLC-MS/MS oxylipin analysis of plasma from ALS patients.
Biomedicines 2022, 10 (3): 674. IF: 4,700.
doi: 10.3390/biomedicines10030674.
Palomés-Borrajo G, Navarro X, Penas C.
BET protein inhibition in macrophages enhances dorsal root ganglion neurite outgrowth in female mice.
J Neurosci Res 2022, 100 (6): 1331-1346. IF: 4,200.
doi: 10.1002/jnr.25036.
Baylo-Marin O, Flores A, Garcia-Alias G.
Long-term rehabilitation reduces task error variability in cervical spinal cord contused rats.
Exp Neurol 2022, 348: 113928. IF: 5,300.
doi: 10.1016/j.expneurol.2021.113928.
Cottilli P, Gaja-Capdevila N, Navarro X.
Effects of Sigma-1 receptor ligands on peripheral nerve regeneration.
Cells 2022, 11 (7): 1083. IF: 6,000.
doi: 10.3390/cells11071083.
Salgado A, Navarro X, Madduri S.
Editorial: Emerging therapeutic approaches for repair and regeneration of injuries in the peripheral nervous system.
Front Bioeng Biotechnol 2022; 10:891459. IF: 5,700.
doi: 10.3389/fbioe.2022.891459.
Contreras E, Bolívar S, Navarro X, Udina E.
New insights into peripheral nerve regeneration: The role of secretomes.
Exp Neurol 2022, 354: 114069. IF: 5,300.
doi: 10.1016/j.expneurol.2022.114069.
Rubio MA, Herrando-Grabulosa M, Gaja-Capdevila N, Vilches JJ, Navarro X.
Characterization of somatosensory neuron involvement in the SOD1G93A mouse model.
Sci Rep 2022, 12 (1): 7600. IF: 4,600.
doi: 10.1038/s41598-022-11767-8.
Gaja‐Capdevila N, Hernández N, Yeste S, Reinoso RF, Burgueño J, Montero A, Merlos M, Vela JM, Herrando‐Grabulosa M, Navarro X.
EST79232 and EST79376, two novel sigma‐1 receptor ligands, exert neuroprotection on models of motoneuron degeneration.
Int J Mol Sci 2022, 23:6737. IF: 5,600.
doi: 10.3390/ijms23126737.
Sánchez-Ventura J, Lane MA, Udina E.
The role and modulation of spinal perineuronal nets in the healthy and injured spinal cord.
Front Cell Neurosci 2022, 16: 893857. IF: 5,300.
doi: 10.3389/fncel.2022.893857.
Vives J, Hernández J, Mirabel C, Puigdomenech-Poch M, Romeo-Guitart D, Marmolejo-Martínez-Artesero S, Cabrera-Pérez R, Jaramillo J, Kumru H, García-López J, Vidal-Samsó J, Navarro X, Coll-Bonet R.
Preclinical development of a therapy for chronic traumatic spinal cord injury in rats using human Wharton’s jelly mesenchymal stromal cells: proof of concept and regulatory compliance.
Cells 2022, 11 (14): 2153. IF: 6,000.
doi: 10.3390/cells11142153.
Cavalcanti F, Gonzalez-Rey E, Delgado M, Falo CP, Mestre L, Guaza C, O’Valle F, Lufino MMP, Xaus J, Mascaró C, Lunardi S, Sacilotto N, Dessanti P, Rotllant D, Navarro X, Herrando-Grabulosa M, Buesa C, Maes T.
Efficacy of Vafidemstat in experimental autoimmune encephalomyelitis highlights the KDM1A/RCOR1/HDAC epigenetic axis in multiple sclerosis.
Pharmaceutics 2022, 14 (7): 1420. IF: 5,400.
doi: 10.3390/pharmaceutics14071420.
Pannunzio B, Amo-Aparicio J, Julián C, López-Vales R, Peluffo H, Lago N.
CD200R1 contributes to successful functional reinnervation after a sciatic nerve injury.
Cells 2022, 11 (11): 1786. IF: 6,000.
doi: 10.3390/cells11111786.
Khiar-Fernández N, Zian D, Vázquez-Villa H, Martínez FR, Escobar-Peña A, Foronda-Sainz R, Ray M, Puigdomenech-Poch M, Cincilla G, Sánchez-Martínez M, Kihara Y, Chun J, López-Vales R, López-Rodríguez M, Ortega-Gutiérrez S.
Novel Antagonist of the type 2 Lysophosphatidic acid receptor (LPA 2), UCM-14216, ameliorates spinal cord injury in mice.
J Med Chem 2022, 65 (16): 10956-10974. IF: 7,300.
doi: 10.1021/acs.jmedchem.2c00046.
Sánchez-Ventura J, Canal C, Hidalgo J, Penas C, Navarro X, Torres-Espin A, Fouad K, Udina E.
Aberrant perineuronal nets alter spinal circuits, impair motor function, and increase plasticity.
Exp Neurol 2022, 358: 114220. IF: 5,300.
doi: 10.1016/j.expneurol.2022.114220.
Contreras E, Bolívar S, Nieto-Nicolau N, Fariñas O, López-Chicón P, Navarro X, Udina E.
A novel decellularized nerve graft for repairing peripheral nerve long gap injury in the rat.
Cell Tissue Res 2022, 390(3):355-366. IF: 3,600.
Correction in Cell Tissue Res 2023; 391(3):611-612.
doi: 10.1007/s00441-022-03682-1.
Bolívar S, Udina E.
Preferential regeneration and collateral dynamics of motor and sensory neurons after nerve injury in mice.
Exp Neurol 2022, 358: 114227. IF: 5,300.
doi: 10.1016/j.expneurol.2022.114227.
Valle G, Aiello G, Ciotti F, Cvancara P, Martinovic T, Kravic T, Navarro X, Stieglitz T, Bumbasirevic M, Raspopovic S.
Multifaceted understanding of human nerve implants to design optimized electrodes for bioelectronics.
Biomaterials 2022, 291:121874. IF: 14,000.
doi: 10.1016/j.biomaterials.2022.121874.
Calls A, Torres-Espin A, Tormo M, Martínez-Escardó L, Bonet N, Casals F, Navarro X, Yuste VJ, Udina E, Bruna J.
A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice.
Ann Clin Transl Neurol 2022, 9 (12): 1985-1998. IF: 5,300.
doi: 0.1002/acn3.51691.
Rubio MA, Herrando-Grabulosa M, Navarro X.
Sensory involvement in Amyotrophic Lateral Sclerosis.
Int J Mol Sci 2022, 23: 15521. IF: 5,600.
doi: 10.3390/ijms232415521.
Contreras E, Traserra S, Bolívar S, Forés J, Jose-Cunilleras E, García F, Delgado-Martínez I, Holmgren S, Strehl R, Udina E, Navarro X.
Repair of long nerve defects with a new decellularized nerve graft in rats and in sheep.
Cells 2022, 11 (24): 4074. IF: 6,000.
doi: 10.3390/cells11244074.
Marco C, Simó M, Alemany M, Casasnovas C, Domínguez R, Vilariño N, Calvo M, Martín-Liberal J, Brenes J, Sabater-Riera J, Bruna J, Velasco R.
Myasthenia Gravis induced by immune checkpoint inhibitors: an emerging neurotoxicity in neuro-oncology practice: Case Series.
J Clin Med 2022, 12 (1): 130. IF: 3,900.
doi: 10.3390/jcm12010130.